Verified Nov 2026
Other
·

Hyderabad, Telangana
·
Since 1981
Natco Pharma is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, Telangana, founded in 1981. The company employs 1,000–5,000 people and generates estimated revenue of $250–500 million. It operates in pharmaceuticals and agrochemicals, serving automotive, electric-vehicle, medical, and industrial-equipment sectors across over 50 countries. Recent activity includes a $14 million additional investment in eGenesis and a $2.5 billion South African expansion.
Natco Pharma at a glance
Revenue
$250-500M
Est. band
Employees
1,000-5,000
Founded
1981
Headquarters
Hyderabad, Telangana
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Natco Pharma is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, Telangana, founded in 1981. The company employs 1,000–5,000 people and generates estimated revenue of $250–500 million. It operates in pharmaceuticals and agrochemicals, serving automotive, electric-vehicle, medical, and industrial-equipment sectors across over 50 countries. Recent activity includes a $14 million additional investment in eGenesis and a $2.5 billion South African expansion.
At a glance
Attribute | Detail |
|---|---|
Founded | 1981 |
Headquarters | Hyderabad, Telangana |
Employees | 1,000-5,000 |
Revenue | $250-500M (estimated) |
What Natco Pharma makes
The company manufactures complex generics, oncology drugs, specialty pharmaceuticals, high-potency active pharmaceutical ingredients, and agrochemical products including the insecticide Chlorantraniliprole.
Products and capabilities described on the company's own site include LED, Emissions (source: natcopharma.co.in).
Latest developments
2026-09-01 — Natco Pharma looks beyond generics for its next growth shot | Company Business News (livemint.com)
2026-08-25 — Natco Pharma invests additional $14 million in eGenesis; total investment hits $22 million - CNBC TV18 (cnbctv18.com)
2026-08-17 — Natco Pharma Reports 44% Q1 Revenue Drop; Plans ₹2000 Crore QIP for Acquisitions, ETPharma (indiatimes.com)
2026-07-14 — Natco Pharma raises Adcock Ingram stake to 49%, pays ₹1060 crore (thehindubusinessline.com)
2026-07-09 — Natco Pharma Invests ₹2500 Crore in South African Expansion, ETPharma (indiatimes.com)
2026-07-08 — Natco Pharma to invest Rs 2,500 crore in South Africa expansion - The Economic Times (indiatimes.com)
Company details
Natco Pharma is a privately held company with significant international presence in the United States, India, Canada, and Brazil, and holds regulatory approvals for biosimilar drugs from the European Medicines Agency. Natco Pharma was founded in 1981, has an estimated 1,000-5,000 employees, and is headquartered in Hyderabad, Telangana.
Frequently asked questions
What does Natco Pharma do?
Natco Pharma is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, Telangana, founded in 1981. The company employs 1,000–5,000 people and generates estimated revenue of $250–500 million. It operates in pharmaceuticals and agrochemicals, serving automotive, electric-vehicle, medical, and industrial-equipment sectors across over 50 countries. Recent activity includes a $14 million additional investment in eGenesis and a $2.5 billion South African expansion.
Where is Natco Pharma headquartered?
Natco Pharma is headquartered in Hyderabad, Telangana (Banjara Hills Road No 2, Hyderabad, Telangana, 500034).
When was Natco Pharma founded?
Natco Pharma was founded in 1981.
How big is Natco Pharma?
Natco Pharma has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
